AI-generated summary
This randomized pilot study of 21 adults with chronic external otitis compared a dual-wavelength LED device at 660 and 940 nm, topical ofloxacin, and both combined over two weeks. The authors report that LED therapy was associated with significant reductions in pain and discomfort and no serious adverse events, while ofloxacin showed the highest otorrhea resolution, though differences were not statistically significant. The small sample size limits the conclusions.
- Participants
- 21
- Who or what was studied
- Adults with chronic external otitis persisting more than 1 month, treated at a tertiary hospital
- Wavelengths
- 660, 940 nm
- Limits stated in the abstract
- The authors describe this as a small pilot study, and the otorrhea difference was not statistically significant (p=0.194), with a floor effect limiting the Group 2 pain comparison.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ejao.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 940 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Phototherapy, Pilot study, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.